Hepatitis E in the EU/EEA, 2005-2015
The purpose of this study was to assess current testing, diagnosis, and surveillance for HEV in EU/EEA Member States, and to conduct a baseline assessment of available epidemiological data.
Options for national testing and surveillance for hepatitis E virus in the EU/EEA - Operational guidance
This operational guidance, developed by ECDC in collaboration with its hepatitis E virus (HEV) expert group, offers options on the implementation or adjustment of HEV surveillance at a national level.
Presentation: Situation overview on hepatitis E in the EU/EEA Member States
Hepatitis E is one of the most common causes of acute hepatitis in the EU/EEA but currently not notifiable at EU level. This presentation summarises ECDC's work on the topic and survey results on hepatitis E on 2005 to 2015 data.